Nordea cancels repurchased shares
Nordea Bank Abp
Stock exchange release – Total number of voting rights and capital
Nordea has today cancelled 8,935,424 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs.
The cancellation brings the total number of shares in Nordea to 3,402,799,099. The total number of votes attached to the shares is 3,402,799,099.
The cancellation of the shares was registered with the Finnish Trade Register on
The company holds 9,045,443 treasury shares for remuneration purposes.
For further information:
Ilkka Ottoila, Head of Investor Relations, +358 9 5300 7058
Media inquiries, +358 10 416 8023 or [email protected]
The information provided in this stock exchange release was submitted for publication, through the agency of the contacts set out above, at 09.15 EET on
Nordea is a leading Nordic financial services group and the preferred choice for millions of customers across the region. For more than 200 years, we have proudly served as a trusted financial partner for individuals, families and businesses – enabling dreams and aspirations for a greater good. Our vision is to be the best-performing financial services group in the Nordics, accelerating through our scale, people and technology. The Nordea share is listed on the Nasdaq Helsinki, Nasdaq Copenhagen and Nasdaq Stockholm exchanges.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/nordea/r/nordea-cancels-repurchased-shares,c4340999
View original content:https://www.prnewswire.com/news-releases/nordea-cancels-repurchased-shares-302755333.html
SOURCE Nordea
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arcadis and Jupiter Intelligence introduce PRICE framework to help organizations close the climate adaptation investment gap
- Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
- Rakuten Medical Announces Executive Leadership Transition to Enhance Operational Execution and Organizational Discipline as a Global, Scalable Biotech Company
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share